Company Profile
Conserv Bioscience Limited
12930143•Private Limited With Share Capital
Get Full Access
05/10/2020
5 years
2
6
21200
very low risk
Company Overview
Registration, classification & business activity
Conserv Bioscience Limited (12930143) is a private limited with share capital incorporated on 05/10/2020 (5 years old) and registered in london, W1T6EB. The company operates under SIC code 21200 - manufacture of pharmaceutical preparations.
Conserv is a late-stage vaccine development company focused on advancing safe and effective vaccines that protect against endemic and emergent infectious diseases. we have a pipeline of eight vaccines in pre-clinical and clinical development including broad-spectrum influenza*, broad-spectrum corona...
Financial Overview
£433.5K
£409.0K
£24.5K
£4.52M
£142.7K
Key Metrics
6
Employees
2
Directors
2
Shareholders
Charges
1
Registered
0
Outstanding
0
Part Satisfied
1
Satisfied
Innovate Grants
This company received a grant of £415262.0 for Pan-Coronavirus Vaccine. The project started on 01/04/2022 and ended on 31/03/2023.
This company received a grant of £680034.0 for A Novel Vaccine Approach Combining Mosquito Salivary Antigens And Viral Antigens To Protect Against Zika, Chikungunya And Other Arboviral Infections.. The project started on 01/10/2023 and ended on 30/09/2025.
+2 more grants available
Import / Export
Risk Assessment
very low risk
International Score
Future Factor
excellent
Performance Rating